|
市場調查報告書
日本的學名藥市場：至2013年的預測
Japanese Generic Market Forecast to 2013
|
日本的學名藥市場：至2013年的預測 是由出版商RNCOS E-Services Pvt. Ltd.在2011年03月所出版的。
這份英文市場調查報告書包含45 Pages 價格從美金800起跳。
日本學名藥市場上，主要的全球規模製藥企業成為中心。這些企業為擴大市佔率，建立策略並與國內廠商合作。Pfizer、Merck、Sandoz等的企業預料在不久的將來，將在日本的市場擴展上扮演重要的角色。
本報告，調查分析日本的學名藥市場，介紹市場的現在動向、對將來產業形成的影響、主要企業的業績等，並包含將來的情境分析，由下列摘要形式闡述。
第1章 分析師的見解
第2章 日本的醫藥品市場：概要
第3章 近期的市場動向
- 國民健康保險適用（NHI）藥局與診斷群分類別整體支付方式（DPC）醫院的重要角色
- 外國學名藥廠商的擴大
- 市場上品質主導型的方式
- 心血管的學名藥
- 致力於市場行銷
第4章 日本的學名藥市場
第5章 消費者行動的分析
第6章 法規環境
第7章 機會評價：學名藥市場
第8章 主要企業
- 澤井製藥
- 日醫工
- 東和藥品
- 日本Chemiphar
- 富士製藥工業
- 大洋藥品工業
圖表
Abstract
Generic drugs are produced and distributed without patent protection and
marketed after the expiry date of patent or other rights. Usually, generic
drugs are as effective as their master drugs and become available to patients
at a very low cost. Due to their low price nature, generic drugs are being
used across the world and the governments are devising strategies to make them
more accessible to society.
Japan is one of the leading pharmaceutical markets in the world; however, the
share of generics has been low. Public perception is the key factor for such a
low share. However, the government has played a vital role in promoting
generic drugs across the country by spreading awareness regarding benefits and
quality. Good promotional activities have largely benefitted Japanese generics
market during the past few years and with total size of around US$ 8 Billion
in 2010, the market is poised to grow at a fast pace. The patent expiry of
branded drugs and active ingredients will act as growth drivers for the market
in future and the government support will strengthen market potential.
Currently, the Japanese generics market is characterized by the presence of
major global pharmaceutical players. These players have been devising
strategies and making alliances with domestic manufacturers to enlarge their
market share. Companies, such as Pfizer, Merck, Sandoz etc. are likely to play
a prominent role in expanding generic drugs market in Japan in near future.
The role of NHI pharmacies and DPC hospitals is also being valued as
exceptional in the positive industry developments. Focus on strong marketing
and cardiovascular generics are the trends positively affecting market in an
effective manner.
The report “Japanese Generic Market Forecast to 2013”
provides an in-depth research and prudent analysis on the generic market in
Japan. It analyzes the current trends prevailing in the generic market and
investigates their impact on the future shape of the industry. The report also
covers the performance of key players in the Japanese generic markets.
Moreover, based on various present and future indicators, the future scenario
of the market has been analyzed and presented in the report.
Table of Contents
1. Analyst View
2. The Japanese Pharmaceutical Market: Overview
3. Recent Market Trends
- 3.1 Important Role of NHI Pharmacies and DPC Hospitals
- 3.2 Expansion of Foreign Generic Drugs Manufacturers
- 3.3 Quality Driven Approach in Market
- 3.4 Cardiovascular Generic Drugs
- 3.5 Renowned Focus on Marketing
4. The Japanese Generic Drugs Market
- 4.1 Industry Overview
- 4.2 Market Segmentation
- 4.3 Distribution Channels
- 4.4 Key Manufacturers
- 4.5 Therapeutic Segment
5. Consumer Behavior Analysis
6. Regulatory Environment
7. Opportunity Assessment: Generic Drugs Market
8. Key Players
- 8.1 Sawai Pharmaceuticals
- 8.2 Nichi-Iko
- 8.3 Towa
- 8.4 Nippon Chemiphar
- 8.5 Fuji Pharma
- 8.6 Taiyo Pharmaceutical
List of Figures:
- Figure 2-1: Pharmaceutical Market (Trillion ¥), 2009-2013
- Figure 2-2: Pharmaceutical Market by Segment (%), 2010
- Figure 4-1: Share of Generic Drugs in Pharmaceuticals Market w.r.t to
Developed Countries (2008)
- Figure 4-2: Asia Pacific - Share of Countries in Generic Drugs Market
(2010)
- Figure 4-3: Generic Drugs Market (Billion US$), 2009-2013
- Figure 4-4: Generic Drugs Market by Segment (%), 2009
- Figure 4-5: Generic Drugs Market by Medical Institution (%), 2008 & 2009
- Figure 4-6: Number of DPC Hospitals (FY 2007 to FY 2009)
- Figure 4-7: Generic Drugs Market by Distribution Channel (%), 2008 & 2009
- Figure 4-8: Market Share of Generic Drugs Manufacturers (2009)
- Figure 6-1: Share of Generic Drugs in Pharmaceuticals Market (Sep 2009 &
Mar 2013)
- Figure 7-1: Generic Drugs Penetration Rate (2005-06 to 2008-09)
- Figure 8-1: Sawai Pharmaceutical - Sales by Therapeutic Category (%), H1
FY 2010
- Figure 8-2: Towa Pharmaceutical - Sales by Therapeutic Category (%), Mar
2010
List of Tables:
- Table 3-1: Key Foreign Generic Drugs Manufacturers in Japan
- Table 4-1: Forecast for Key Macroeconomic Indicators
- Table 4-2: Key Tie-ups & Alliances in Generic Drugs Market (2008-2010)
- Table 4-3: Generic Drugs Prescriptions by Therapeutic Category (%)
- Table 6-1: Key Measures for Generic Drugs Promotion
- Table 7-1: Patent Expiry of Key Active Ingredients (2011 & 2012)
|
